``To optimize their capabilities and sharpen their customer value...
Category:
Non-Life
Latest
‘Heal in Rajasthan’ policy to boost medical tourism in desert state
Additional Chief Secretary of the Health Department Shubhra Singh...
Govt directs Reliance General to pay Rs 225 cr to Maha farmers in a week
Shivraj Singh Chouhan ,Union Agriculture Minister On August 22, the...
17 pc dip in average fresh COVID-19 cases since 2nd Corona wave peak in May, says Union Health Ministry
The Union Health Ministry further added that a total of 51 Delta plus variant cases reported in India. In regard to the Moderna COVID-19 vaccine, Dr VK Paul, Member-Health of Niti Aayog said, “New drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use.”
GIC Re’s net profit rises 5 % to Rs 1260 crore, cuts gross premium 4% to Rs 8813 crore in Q4 Fy 21
With a combined ratio of 103.9 per cent(107.6 per cent), GIC Re’s underwriting loss has gone up by 15 per cent y-o-y to Rs 535 crore during the fourth quarter of Fy 2021.
The net investment income of the reinsurer has increased by 20 per cent y-o-y to R 2286 crore in the foutth quater of Fy 2021.For the whole of FY 2021,
SC orders implementation of ‘one nation, one ration card scheme’ by July 31
The bench directed the Centre to develop a portal with the help of the National Informatics Centre (NIC) for registration of unorganised sector workers for granting them the benefits of welfare schemes by July 31.
Cipla gets DCGI nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India: Sources
According to the sources, approval is likely anytime as the Central Drugs Standard Control Organisation (CDSCO) is in favor of granting permission to Cipla for import of Moderna’s COVID-19 vaccine for restricted emergency use in India considering the pandemic situation in the country and the public interest.
Johnson & Johnson exploring ways to accelerate delivery of its COVID vaccine in India
‘We are in ongoing discussions with the Government of India and are exploring how best to accelerate our ability to deliver the Johnson & Johnson single dose COVID-19 vaccine to the people of India,” Johnson & Johnson India spokesperson said in a statement.
As per the recent announcement by the Drugs Controller General of India (DCGI), there is no longer a requirement to conduct bridging clinical studies of COVID-19 vaccines in India, the statement added.
Five Indian drugmakers to jointly start local trial of Merck & Co’s COVID-19 drug
Between March and April, each of these companies, including Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure Pharmaceuticals, partnered with Merck to expand production of the drug, molnupiravir, hastening its availability in India to address a new wave of infections in the country.
Oxford study says mixing COVID-19 vaccines gives good protection
Professor Snape said these results are an invaluable guide to the use of mixed dose schedules, but the interval of four weeks studied here is shorter than the eight to 12-week schedule most commonly used for the Oxford-AstraZeneca vaccine.
Google, FB to appear before Parliamentary Panel on IT
On June 20, India’s permanent mission at the United Nations had clarified that India’s new IT rules are “designed to empower ordinary users of social media” and that they were finalised after the government held broad consultations with civil society and other stakeholders in 2018.
Don’t create panic about 3rd wave, basic manta is ‘precaution, no panic’: Jitendra Singh to docs
All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said, ”As we now prepare for the possibility of the third wave and (the spread of) new variants like Delta Plus… we need to look ahead and see how we can strengthen our public health system focusing on lessons we have learnt from the past.”
Greece offers cash reward to boost vaccination rates in young people
“With the first jab of the vaccine (they) will get a prepaid card of 150 euros,” Greek Prime Minister Kyriakos Mitsotakis told a ministerial meeting, presenting the new incentive. “It’s a debt to the youth, a gift out of gratitude,” he added.